Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-01-29 4 S $94.32 $72,343 D/D (767) 84,497 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-02-04 4 S $95.66 $246,081 D/D (2,572) 81,925 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-02-06 4 A $0.00 $0 D/D 4,500 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-03-08 4 S $91.21 $1,827,162 D/D (20,000) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-03-08 4 OE $17.98 $390,350 D/D 20,000 128,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-04-29 4 AS $98.96 $3,612,051 D/D (36,499) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-04-29 4 OE $22.90 $1,231,027 D/D 36,499 144,961 0 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-07-01 4 AS $94.34 $4,190,622 D/D (44,125) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-07-01 4 OE $22.90 $1,726,762 D/D 44,125 152,587 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-12 4 AS $119.90 $2,158,200 D/D (18,000) 108,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-12 4 OE $17.98 $378,370 D/D 18,000 126,462 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-30 4 S $110.86 $124,163 D/D (1,120) 107,342 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-08-02 4 AS $114.95 $1,629,018 D/D (14,125) 107,342 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-08-02 4 OE $22.90 $446,963 D/D 14,125 121,467 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-08-05 4 S $116.87 $99,573 D/D (852) 106,490 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-09-13 4 S $114.37 $114,370 I/I (1,000) 105,490 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-09-24 4 S $112.54 $34,212 I/I (304) 105,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-10-28 4 S $123.89 $123,890 I/I (1,000) 104,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-10-28 4 S $124.06 $4,967,340 D/D (40,037) 105,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-10-28 4 OE $78.88 $3,271,739 D/D 40,037 145,223 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-04 4 OE $22.90 $446,963 D/D 14,125 118,311 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-04 4 AS $123.82 $1,749,664 D/D (14,125) 104,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-22 5 GD $0.00 $0 D/D 420 104,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-01-29 4 S $133.21 $149,039 D/D (1,118) 103,068 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-03 4 S $157.14 $133,883 D/D (852) 102,216 0 -
  148  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us